Integral Health Asset Management’s Precision BioSciences DTIL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-11,667
| Closed | -$1.08M | – | 73 |
|
|
2022
Q1 | $1.08M | Buy |
11,667
+5,834
| +100% | +$539K | 0.28% | 63 |
|
|
2021
Q4 | $1.3M | Buy |
5,833
+1,666
| +40% | +$370K | 0.36% | 59 |
|
|
2021
Q3 | $1.44M | Sell |
4,167
-1,666
| -29% | -$577K | 0.41% | 60 |
|
|
2021
Q2 | $2.19M | Buy |
+5,833
| New | +$2.19M | 0.6% | 49 |
|
|
2021
Q1 | – | Sell |
-4,667
| Closed | -$1.17M | – | 76 |
|
|
2020
Q4 | $1.17M | Sell |
4,667
-5,333
| -53% | -$1.33M | 0.35% | 55 |
|
|
2020
Q3 | $1.85M | Buy |
+10,000
| New | +$1.85M | 0.57% | 57 |
|
|
2020
Q1 | – | Sell |
-1,667
| Closed | -$695K | – | 59 |
|
|
2019
Q4 | $695K | Buy |
+1,667
| New | +$695K | 0.27% | 50 |
|